Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-16,389
Closed -$785K 598
2021
Q4
$785K Buy
+16,389
New +$735K ﹤0.01% 490
2020
Q4
Sell
-100,000
Closed -$1.73M 429
2020
Q3
$1.73M Sell
100,000
-50,000
-33% -$871K 0.01% 259
2020
Q2
$2.46M Buy
+150,000
New +$2.28M 0.01% 193

Other funds holding ADNT

Brookfield Corp's ADNT Position: Q1 2022 in Review

Brookfield Corp sold out of Adient (ADNT) in Q1 2022, closing a stake of 16,389 shares — an estimated $785K sold.

Brookfield Corp first reported a position in ADNT in Q2 2020 and held it in 3 quarters. The position peaked at $2.46M in Q2 2020. 271 funds tracked by Wall St. Rank hold ADNT as of Q1 2022.

  • Brookfield Corp reported no remaining Adient position as of Q1 2022 after selling out during the quarter.
  • Brookfield Corp sold 16,389 Adient shares in Q1 2022, an estimated $785K.
  • Brookfield Corp first reported a position in Adient in Q2 2020 and held it in 3 quarters.
  • Brookfield Corp's Adient position peaked at $2.46M in Q2 2020.
  • 271 funds tracked by Wall St. Rank held Adient as of Q1 2022.

Based on Brookfield Corp's 13F filing for Q1 2022, filed 16 May 2022.